This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Gremubamab
- DrugBank Accession Number
- DB15014
- Background
-
Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).
- Type
- Biotech
- Groups
- Investigational
- Synonyms
-
- Gremubamab
- External IDs
-
- MEDI3902
Ph值armacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support. - Ph值armacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- Volume of distribution
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data. - Toxicity
-
Not Available
- Pathways
- Not Available
- Ph值armacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbciximab 不利影响的风险或严重性可以公司reased when Abciximab is combined with Gremubamab. Adalimumab 不利影响的风险或严重性可以公司reased when Adalimumab is combined with Gremubamab. Aducanumab 不利影响的风险或严重性可以公司reased when Aducanumab is combined with Gremubamab. Alemtuzumab 不利影响的风险或严重性可以公司reased when Alemtuzumab is combined with Gremubamab. Alirocumab 不利影响的风险或严重性可以公司reased when Alirocumab is combined with Gremubamab. Amivantamab 不利影响的风险或严重性可以公司reased when Gremubamab is combined with Amivantamab. Anifrolumab 不利影响的风险或严重性可以公司reased when Anifrolumab is combined with Gremubamab. Ansuvimab 不利影响的风险或严重性可以公司reased when Gremubamab is combined with Ansuvimab. Anthrax immune globulin human 不利影响的风险或严重性可以公司reased when Anthrax immune globulin human is combined with Gremubamab. Antilymphocyte immunoglobulin (horse) 不利影响的风险或严重性可以公司reased when Antilymphocyte immunoglobulin (horse) is combined with Gremubamab. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3QG7W0YN2Z
- CAS number
- 1800381-36-5
References
- 一般引用
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Ph值ase Status Purpose Conditions Count 2 Completed Prevention Pseudomonas Aeruginosa 1 1 Completed Prevention MEDI3902 for Prevention of P. Aeruginosa Pneumonia 1
Ph值armacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at May 20, 2019 14:42 / Updated at February 21, 2021 18:55